Ayala G - Search Results

1

Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.

Ayala G, Morello M, Frolov A, You S, Li R, Rosati F, Bartolucci G, Danza G, Adam RM, Thompson TC, Lisanti MP, Freeman MR, Vizio DD. Ayala G, et al. J Pathol. 2013 Sep;231(1):77-87. doi: 10.1002/path.4217. Epub 2013 Jul 8. J Pathol. 2013. PMID: 23729330 Free PMC article.

2

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.

Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G. Li R, et al. Among authors: ayala g. Am J Surg Pathol. 2004 Jul;28(7):928-34. doi: 10.1097/00000478-200407000-00013. Am J Surg Pathol. 2004. PMID: 15223964

3

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, Thompson TC, Harper JW. Yang G, et al. Among authors: ayala g. Clin Cancer Res. 2002 Nov;8(11):3419-26. Clin Cancer Res. 2002. PMID: 12429629

4

Neural cell adhesion molecule is upregulated in nerves with prostate cancer invasion.

Li R, Wheeler T, Dai H, Ayala G. Li R, et al. Among authors: ayala g. Hum Pathol. 2003 May;34(5):457-61. doi: 10.1016/s0046-8177(03)00084-4. Hum Pathol. 2003. PMID: 12792919

5

Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC. Tahir SA, et al. Among authors: ayala g. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3653-9. Clin Cancer Res. 2003. PMID: 14506154

6

Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.

Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A, Ayala G. Li R, et al. Among authors: ayala g. Prostate. 2004 Feb 1;58(2):193-9. doi: 10.1002/pros.10321. Prostate. 2004. PMID: 14716745

7

High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.

Ayala G, Thompson T, Yang G, Frolov A, Li R, Scardino P, Ohori M, Wheeler T, Harper W. Ayala G, et al. Clin Cancer Res. 2004 Oct 1;10(19):6572-8. doi: 10.1158/1078-0432.CCR-04-0477. Clin Cancer Res. 2004. PMID: 15475446

8

Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.

Dai H, Li R, Wheeler T, Diaz de Vivar A, Frolov A, Tahir S, Agoulnik I, Thompson T, Rowley D, Ayala G. Dai H, et al. Among authors: ayala g. Prostate. 2005 Nov 1;65(3):276-86. doi: 10.1002/pros.20294. Prostate. 2005. PMID: 16015593

9

Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.

Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D. Tahir SA, et al. Among authors: ayala g. Clin Cancer Res. 2006 Aug 15;12(16):4872-5. doi: 10.1158/1078-0432.CCR-06-0417. Clin Cancer Res. 2006. PMID: 16914574

10

FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.

Yu W, Feng S, Dakhova O, Creighton CJ, Cai Y, Wang J, Li R, Frolov A, Ayala G, Ittmann M. Yu W, et al. Among authors: ayala g. Clin Cancer Res. 2011 Jul 1;17(13):4355-66. doi: 10.1158/1078-0432.CCR-10-2858. Epub 2011 May 27. Clin Cancer Res. 2011. PMID: 21622724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

663 results

Search Page

Filters